Hormonal composition consisting of an oestrogen compound and of a progestational compound
US6831073B1 · kind B1 · utility
7Cited by
5References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 17, 1999 |
| Grant date | Dec 14, 2004 |
| Priority date | — |
| Expiry date | Mar 17, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/811
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating estrogenic deficiencies in women while further avoiding the appearance of osteoporosis, withdrawal bleeding and cardiovascular diseases in post-menopausal women without any androgenic effect, and no deleterious effects on blood vessels comprising continuously without interruption administering to said women, a combination of 0.5 to 3 mg of an estrogenic compound and 1.5 to 3.75 mg of nomegestrol acetate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.